1Oliveras A, Sierra Ade L. New developments in the diagnosis and manage- ment of resistant hypertension[ J ]. Curr Med Chem, 2012, 19 (8) : 1210 - 1218.
2Peet MM, Isberg EM. The surgical treatment of arterial hypertension[J]. Med Press Egypt, 1946,38(6) : 176 - 185.
3Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension. [ J ]. Am J Cardiol, 2010,105 (4) : 570 - 576.
4Rosas-Arellano MP, Solano-Flores LP, Ciriello J. c-Fos induction in spinal cord neurons after renal arterial or venous occlusion [ J ]. Am J Physiol, 1999,276(1Pt 2) :R120 - 127.
5van Vark LC, Bertrand M, Akkerhuis KM, et al. Angiotensin-eonverting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of ran- domized clinical trials of renin-angiotensin-aldosterone system iilhibitors in- volving 158998 patients[J]. Eur Heart J,2012,33(16) :2088 - 2097.
7Ciriello J, de Oliveira CV. Renal afferents and hypertension[J]. Curt Hy- pertens Rep,2002,4(2) : 136 - 142.
8Schlaich MP, Sobotka PA, Knnn H, et al. Renal sympatheticnerve abla- tion for uncontrolled hypertension[J]. N Engl J Med,2009,361(9) :932 - 934.
9Prochnan D, Figulla HR, Surber R. Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long- term follow-up[J]. Int J Cardiol,2012,157(3) :447 - 448.
10Ahmed H, Neuzil P, Skoda J, et al. Renal sympathetic denervation usingan irrigated radiofrequency ablation catheter for the management of drug-re- sistant hypertension [ J ]. JACC Cardiovasc Interv, 2012,5 (7) : 758 - 765.
